Earnings ·
Reports Q3 revenue of $12.7M, up 22%, and raises full-year guidance to $46-48 million
TKNOAlpha Teknova, Inc.
Alpha Teknova reported third-quarter total revenue of $12.7 million, a 22% increase from the prior year period, driven by growth in Lab Essentials and Clinical Solutions segments. The company raised its fiscal 2026 revenue guidance to $46-48 million while maintaining expectations for full-year free cash outflow of less than $8 million. Additionally, Alpha Teknova announced the completion of a $46 million public equity offering in October 2026 and launched its Fill-Tek Dispensing System. The company operates as a producer of critical reagents for life sciences, diagnostics, and therapeutic development.